+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclandelate Market by Product Type, Route Of Administration, Distribution Channel, End User, Application, Dosage Strength - Global Forecast to 2030- Product Image
Cyclandelate Market by Product Type, Route Of Administration, Distribution Channel, End User, Application, Dosage Strength - Global Forecast to 2030- Product Image
Sale

Cyclandelate Market by Product Type, Route Of Administration, Distribution Channel, End User, Application, Dosage Strength - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083084
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cyclandelate market is progressing against a backdrop of rising demand for effective vascular therapies, increasing competition from generics, and evolving distribution models. Senior executives navigating this space face a landscape shaped by shifting regulatory measures, heightened patient centricity, and rapidly changing procurement frameworks.

Market Snapshot: Cyclandelate Market Overview

The Cyclandelate market expanded from USD 677.33 million in 2024 to USD 711.11 million in 2025 and is projected to sustain this upward momentum with a CAGR of 4.94%, reaching USD 904.94 million by 2030. This growth reflects changing patient needs, manufacturer innovation, expanding global access, and an active competitive environment. Industry players are building strategies to address distribution realignment, pricing pressures from generics, and new opportunities in digital channels and home healthcare.

Scope & Segmentation

  • Product Types: Branded and generic formulations are both available, each with specific market positioning reflecting the balance between clinical trust and cost-effectiveness.
  • Route of Administration: Options cover injectable (intramuscular, intravenous) and oral (capsule, liquid, tablet) formats, serving diverse treatment settings and patient preferences.
  • Distribution Channels: Hospital pharmacy, retail pharmacy, online pharmacy, third-party platforms, and proprietary websites play essential roles in product accessibility.
  • End Users: Clinics (outpatient, specialty centers), hospitals (primary, secondary, tertiary), and home care facilities each drive specific prescribing and procurement dynamics.
  • Applications: Addressing both cerebral and peripheral vascular diseases, Cyclandelate's use is supported by therapeutic guidelines across neurology and vascular medicine.
  • Dosage Strengths: Available in 100 mg and 50 mg presentations, aligning with tailored physician and patient needs.
  • Regions: Coverage spans the Americas (including the US, Canada, Brazil, Argentina, Mexico), Europe, Middle East & Africa (comprising key markets such as the UK, Germany, Saudi Arabia, South Africa), and Asia-Pacific (notably China, India, Japan, Australia, South Korea).
  • Key Companies: Leading innovators include Sandoz International GmbH, Teva Pharmaceuticals International GmbH, Viatris Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Fresenius Kabi AG, Lupin Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, and Aurobindo Pharma Ltd.

Key Takeaways for Senior Decision-Makers

  • Branded Cyclandelate maintains strong clinical adoption in established hospital systems, while generics capitalize on broader accessibility and value-driven procurement.
  • Oral formulations are accelerating uptake among home-based and outpatient populations, challenging the dominance of traditional injectable therapies in acute care.
  • The proliferation of digital pharmacy channels and online retail is prompting firms to refine omnichannel strategies for distribution and patient engagement.
  • Manufacturers are leveraging strategic partnerships—particularly among API suppliers, regional distributors, and contract manufacturers—to ensure resilience and supply chain efficiency amidst regulatory and tariff changes.
  • Regional heterogeneity demands adaptable go-to-market models, with the Americas prioritizing consolidated hospital distribution, EMEA balancing public-private frameworks, and Asia-Pacific driving retail pharmacy integration and reimbursement reform.

Tariff Impact: Navigating US Trade Dynamics

Recent US import tariffs on pharmaceutical ingredients have affected production costs and supply chain structures across the Cyclandelate market. Manufacturers are responding by investing in local API synthesis and contract manufacturing operations to mitigate these pressures. Distribution stakeholders—particularly hospital pharmacies and online platforms—are reevaluating sourcing strategies to stabilize pricing and maintain continuity. In response, some regions have introduced phased tariff reductions for essential cardiovascular therapies, seeking to balance fiscal objectives with the need for public health resilience.

Methodology & Data Sources

This report’s findings are informed by a multifaceted research framework that integrates a review of peer-reviewed journals, regulatory filings, clinical trials, and patent databases. Primary inputs were provided by interviews with field experts in neurology, vascular medicine, pharmaceutical development, and supply chain management. Analytical rigor was ensured through data triangulation and validation against regional distributor and payor perspectives. Company profiles reflect disclosures, investor updates, and strategic partnership filings.

Why This Report Matters

  • Enables senior leaders to benchmark their strategies with a comprehensive, regionally nuanced market analysis.
  • Delivers actionable insights on portfolio optimization, supply chain adaptation, and channel selection amid ongoing regulatory and competitive shifts.
  • Equips organizations to anticipate and address critical challenges related to pricing, patient engagement, and market access across multiple geographies.

Conclusion

Cyclandelate's market outlook is defined by technological adoption, responsive distribution models, and evolving policy landscapes. Executives who align their offerings with these complex dynamics are well positioned to lead sustained growth and capture emerging opportunities within this vital therapeutic category.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cyclandelate Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Cyclandelate Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral
9.3.1. Capsule
9.3.2. Liquid
9.3.3. Tablet
10. Cyclandelate Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Third-Party Platform
10.3.2. Website
10.4. Retail Pharmacy
11. Cyclandelate Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Outpatient Clinics
11.2.2. Specialty Centers
11.3. Home Care
11.4. Hospitals
11.4.1. Primary Hospitals
11.4.2. Secondary Hospitals
11.4.3. Tertiary Hospitals
12. Cyclandelate Market, by Application
12.1. Introduction
12.2. Cerebral Vascular Disease
12.3. Peripheral Vascular Disease
13. Cyclandelate Market, by Dosage Strength
13.1. Introduction
13.2. 100 Mg
13.3. 50 Mg
14. Americas Cyclandelate Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cyclandelate Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cyclandelate Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sandoz International GmbH
17.3.2. Teva Pharmaceuticals International GmbH
17.3.3. Viatris Inc.
17.3.4. Fresenius Kabi AG
17.3.5. Dr. Reddy’s Laboratories Ltd.
17.3.6. Sun Pharmaceutical Industries Ltd.
17.3.7. Lupin Ltd.
17.3.8. Cipla Ltd.
17.3.9. Hikma Pharmaceuticals PLC
17.3.10. Aurobindo Pharma Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CYCLANDELATE MARKET MULTI-CURRENCY
FIGURE 2. CYCLANDELATE MARKET MULTI-LANGUAGE
FIGURE 3. CYCLANDELATE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CYCLANDELATE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CYCLANDELATE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CYCLANDELATE MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CYCLANDELATE MARKET SIZE, BY WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CYCLANDELATE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CYCLANDELATE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CYCLANDELATE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CYCLANDELATE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CYCLANDELATE MARKET SIZE, BY PRIMARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CYCLANDELATE MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CYCLANDELATE MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CYCLANDELATE MARKET SIZE, BY 100 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CYCLANDELATE MARKET SIZE, BY 50 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 71. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. CANADA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. CANADA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. GERMANY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. GERMANY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. GERMANY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 167. ITALY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 170. ITALY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 171. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. ITALY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 173. ITALY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ITALY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 175. ITALY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. SPAIN CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 181. SPAIN CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 182. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. SPAIN CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 184. SPAIN CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SPAIN CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. SPAIN CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. SPAIN CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 222. DENMARK CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. DENMARK CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. DENMARK CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 225. DENMARK CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 226. DENMARK CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. DENMARK CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. DENMARK CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 230. DENMARK CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 244. QATAR CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. QATAR CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. QATAR CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 247. QATAR CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 248. QATAR CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. QATAR CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. QATAR CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. QATAR CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 252. QATAR CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. QATAR CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. QATAR CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 255. FINLAND CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. FINLAND CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 258. FINLAND CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 259. FINLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. FINLAND CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 261. FINLAND CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. FINLAND CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. FINLAND CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. FINLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 288. EGYPT CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. EGYPT CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 291. EGYPT CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 292. EGYPT CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. EGYPT CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 294. EGYPT CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. EGYPT CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 296. EGYPT CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. EGYPT CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. EGYPT CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 299. TURKEY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. TURKEY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. TURKEY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 302. TURKEY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 303. TURKEY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. TURKEY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 305. TURKEY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. TURKEY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 321. NORWAY CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. NORWAY CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. NORWAY CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 324. NORWAY CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 325. NORWAY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. NORWAY CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 327. NORWAY CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. NORWAY CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. NORWAY CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 330. NORWAY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. NORWAY CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 332. POLAND CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. POLAND CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 334. POLAND CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 335. POLAND CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 336. POLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. POLAND CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 338. POLAND CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. POLAND CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 340. POLAND CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. POLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. POLAND CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 351. SWITZERLAND CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 352. SWITZERLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 354. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 355. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 356. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 357. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 358. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 359. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 360. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 361. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 362. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 363. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 364. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 365. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 366. CHINA CYCLANDELATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 367. CHINA CYCLANDELATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 368. CHINA CYCLANDELATE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 369. CHINA CYCLANDELATE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 370. CHINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 371. CHINA CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 372. CHINA CYCLANDELATE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 373. CHINA CYCLANDELATE MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cyclandelate market report include:
  • Sandoz International GmbH
  • Teva Pharmaceuticals International GmbH
  • Viatris Inc.
  • Fresenius Kabi AG
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Ltd.
  • Cipla Ltd.
  • Hikma Pharmaceuticals PLC
  • Aurobindo Pharma Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 711.11 Million
Forecasted Market Value ( USD ) by 2030 $ 904.94 Million
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cyclandelate (CAS 456-59-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cyclandelate (CAS 456-59-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
a-Acetyldigitoxin Market by Distribution Channel, End User, Dosage Form, Route Of Administration, Application - Global Forecast to 2030 - Product Image

a-Acetyldigitoxin Market by Distribution Channel, End User, Dosage Form, Route Of Administration, Application - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Angina Pectoris Drugs Market by Drug Class, Dosage Form, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of Administration (Oral, Parenteral), By Distribution Channel, By Region, and Segment Forecasts, 2025 - 2030 - Product Image

Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of Administration (Oral, Parenteral), By Distribution Channel, By Region, and Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From

About the Cyclandelate Market

Cyclandelate is a cardiovascular drug used to treat peripheral vascular disease, a condition in which the blood vessels in the legs become narrowed and hardened. It works by dilating the blood vessels, allowing more blood to flow through them and reducing the symptoms of the disease. Cyclandelate is available in both oral and topical forms, and is often used in combination with other medications to treat the condition. Cyclandelate is a widely used drug in the cardiovascular market, with many pharmaceutical companies producing and marketing it. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.